Systematic review: Granulocyte/monocyte adsorptive apheresis for ulcerative colitis

Alimentary Pharmacology and Therapeutics

Volumn 32, Issue 11-12, 2010, Pages 1297-1306

  Thanaraj, S ^a   Hamlin, P J ^a   Ford, A C ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5 ACETAMIDOSALICYLIC ACID; AZATHIOPRINE; CORTICOSTEROID; MERCAPTOPURINE; PREDNISOLONE;

APHERESIS; COMPARATIVE STUDY; DRUG EFFECT; GRANULOCYTE MONOCYTE ADSORPTIVE APHERESIS; HUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; REMISSION; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; TREATMENT RESPONSE; ULCERATIVE COLITIS; UNSPECIFIED SIDE EFFECT;

ADSORPTION; BLOOD COMPONENT REMOVAL; CHRONIC DISEASE; COLITIS, ULCERATIVE; GRANULOCYTES; HUMANS; MONOCYTES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 78449268932     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2010.04490.x     Document Type: Review

References (37)

1. Loftus EV Jr, Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR,. Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gut 2000; 46: 336 - 43.
2. Loftus CG, Loftus EV Jr, Harmsen WS, et al. Update on the incidence and prevalence of Crohns disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflamm Bowel Dis 2007; 13: 254 - 61.
3. Kappelman MD, Rifas-Shiman SL, Kleinman K, et al. The prevalence and geographic distribution of Crohns disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol 2007; 5: 1424 - 9.
4. Bernklev T, Jahnsen J, Henriksen M, et al. Relationship between sick leave, unemployment, disability, and health-related quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis 2006; 12: 402 - 12.
5. Boonen A, Dagnelie PC, Feleus A, et al. The impact of inflammatory bowel disease on labor force participation: results of a population sampled case-control study. Inflamm Bowel Dis 2002; 8: 382 - 9.
6. Lennard-Jones JE, Longmore AJ, Newell AC, Wilson CWE, Avery Jones F,. An assessment of prednisone, salazopyrin, and topical hydrocortisone hemisuccinate used as out-patient treatment for ulcerative colitis. Gut 1960; 1: 217 - 22.
7. Truelove SC, Witts LJ,. Cortisone in ulcerative colits: final report on a therapeutic trial. Br Med J 1955; 2: 1041 - 8.
8. Sutherland L, MacDonald JK,. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 2006; 2: CD000543.
9. Jewell DP, Truelove SC,. Azathioprine in ulcerative colitis: final report on controlled therapeutic trial. Br Med J 1974; 4: 627 - 30.
10. Sood A, Kaushal V, Midha V, Bhatia KL, Sood N, Malhotra V,. The beneficial effect of azathioprine on maintenance of remission in severe ulcerative colitis. J Gastroenterol 2002; 37: 270 - 4.
11. Sutherland L, MacDonald JK,. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis (Review). Cochrane Database Syst Rev 2006; 2: CD000544.
12. Timmer A, McDonald JW, MacDonald JK,. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev 2007; 1: CD000478.
13. Faubion WA Jr, Loftus EV Jr, Harmsen WS, Zinsmeister AR, Sandborn WJ,. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology 2002; 121: 255 - 60.
14. Ho GT, Chiam P, Drummond H, Loane J, Arnott ID, Satsangi J,. The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5-year UK inception cohort. Aliment Pharmacol Ther 2006; 24: 319 - 30.
15. UK IBD Audit Steering Group. UK IBD Audit 2nd Round (2008) Report: National Results for the Organisation and Process of Adult IBD Care in the UK (Generic Hospital Report). Available at:. Accessed July 2010.
16. Lichtenstein GR, Cohen R, Yamashita B, Diamond RH,. Quality of life after proctocolectomy with ileoanal anastamosis for patients with ulcerative colitis. J Clin Gastroenterol 2006; 40: 669 - 77.
17. National Institute for Health and Clinical Excellence. Infliximab for Subacute Manifestations of Ulcerative Colitis. Available at:. Accessed July 2010.
18. Williams JG,. Phagocytes, toxic oxygen metabolites and inflammatory bowel disease: implications for treatment. Ann R Coll Surg Eng 1990; 72: 253 - 62.
19. Kashiwagi N, Sugimura K, Koiwai H, et al. Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis. Dig Dis Sci 2002; 47: 1334 - 41.
20. Shimoyama T, Sawada K, Hiwatashi N, et al. Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study. J Clin Apher 2001; 16: 1 - 9.
21. Yamamoto T, Umegae S, Kitagawa T, et al. Granulocyte and monocyte adsorptive apheresis in the treatment of active distal ulcerative colitis: a prospective, pilot study. Aliment Pharmacol Ther 2004; 20: 783 - 92.
22. Suzuki Y, Yoshimura N, Saniabadi AR, Saito Y,. Selective granulocyte and monocyte adsorptive apheresis as a first-line treatment for steroid nave patients with active ulcerative colitis: a prospective uncontrolled study. Dig Dis Sci 2004; 49: 565 - 71.
23. Higgins JPT, Green S,. Cochrane Handbook for Systematic Reviews of Interventions: Version 5.0.0. 2008. Available at:. Accessed July 2010.
24. Hanai H, Watanabe F, Yamada M, et al. Adsorptive granulocyte and monocyte apheresis versus prednisolone in patients with corticosteroid-dependent moderately severe ulcerative colitis. Digestion 2004; 70: 36 - 44.
25. Hanai H, Iida T, Takeuchi K, et al. Intensive granulocyte and monocyte adsorption versus intravenous prednisolone in patients with severe ulcerative colitis: an unblinded randomised multi-centre controlled study. Dig Liver Dis 2008; 40: 433 - 40.
26. Sands BE, Sandborn WJ, Feagan BG, et al. A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis. Gastroenterology 2008; 135: 400 - 9.
27. Sakuraba A, Motoya S, Watanabe K, et al. An open-label prospective randomized multicenter study shows very rapid remission of ulcerative colitis by intensive granulocyte and monocyte adsorptive apheresis as compared with routine weekly treatment. Am J Gastroenterol 2009; 104: 2990 - 5.
28. Sakuraba A, Sato T, Naganuma M, et al. A pilot open-labeled prospective randomized study between weekly and intensive treatment of granulocyte and monocyte adsorption apheresis for active ulcerative colitis. J Gastroenterol 2008; 43: 51 - 6.
29. Ricart E, Esteve M, Andreu M, et al. Evaluation of 5 versus 10 granulocyteaphaeresis sessions in steroid-dependent ulcerative colitis: a pilot, prospective, multicenter, randomized study. World J Gastroenterol 2007; 13: 2193 - 7.
30. Dignass AU, Eriksson A, Kilander A, Pukitis A, Rhodes JM, Vavricka S,. Clinical trial: five or ten cycles of granulocyte-monocyte apheresis show equivalent efficacy and safety in ulcerative colitis. Aliment Pharmacol Ther 2010; 31: 1286 - 95.
31. Nakamura T, Kawagoe Y, Matsuda T, et al. Effect of granulocyte and monocyte adsorption apheresis on urinary albumin excretion and plasma endothelin-1 concentration in patients with active ulcerative colitis. Blood Purif 2004; 22: 499 - 504.
32. Shimoyama T, Sawada K, Tanaka T, et al. Granulocyte and monocyte apheresis with the G-1 column in the treatment of patients with active ulcerative colitis. Jpn J Apher 1999; 18: 117 - 31.
33. Juni P, Altman DG, Egger M,. Assessing the quality of controlled clinical trials. Br Med J 2001; 323: 42 - 6.
34. Habermalz B, Sauerland S,. Clinical effectiveness of selective granulocyte, monocyte adsorptive apheresis with the Adacolumn device in ulcerative colitis. Dig Dis Sci 2010; 55: 1421 - 8.
35. Thanaraj S, Hamlin PJ, Ford AC,. Is the benefit of granulocyte monocyte adsorptive apheresis in ulcerative colitis overstated? Dig Dis Sci 2010; 55: 1803.
36. Bresci G, Parisi G, Mazzoni A, Scatena F, Capria A,. Treatment of patients with acute ulcerative colitis: conventional corticosteroid therapy (MP) versus granulocytapheresis (GMA): a pilot study. Dig Liver Dis 2007; 39: 430 - 4.
37. Higgins JPT, Thompson SG, Deeks JJ, Altman DG,. Measuring inconsistency in meta-analyses. Br Med J 2003; 327: 557 - 60.